{
    "clinical_study": {
        "@rank": "137874", 
        "arm_group": {
            "arm_group_label": "St John's wort", 
            "arm_group_type": "Experimental", 
            "description": "Subjects will undergo 3 oral glucose tolerance tests:\nWithout taking any St John's wort\nAfter 3 weeks pretreatment with St John's wort\nMinimum 6 weeks after last St John's wort ingestion"
        }, 
        "brief_summary": {
            "textblock": "The goal of the study is to examine if healthy individuals that ingest St John's wort will\n      have a significantly difference in glucose tolerance."
        }, 
        "brief_title": "Does the Natural Medicinal Plant St John's Wort Affect the Glucose Tolerance in Healthy Individuals", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 2 Diabetes", 
        "condition_browse": {
            "mesh_term": "Diabetes Mellitus, Type 2"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18-40 years\n\n          -  Males\n\n          -  Fasting plasma-glucose < 7.0 mmol/L\n\n          -  Glycosylated haemoglobin A1c within reference or clinically insignificant deviation\n             hereof\n\n          -  Body mass index < 30 kg/m^2\n\n        Exclusion Criteria:\n\n          -  Hypersensitivity to St John's wort\n\n          -  Chronical or daily alcohol abuse\n\n          -  Known liver disease\n\n          -  Ingestion of drugs requiring prescription, except locally acting drugs"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01921881", 
            "org_study_id": "AKF-385"
        }, 
        "intervention": {
            "arm_group_label": "St John's wort", 
            "intervention_name": "St John's wort", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Glucose tolerance", 
        "lastchanged_date": "November 1, 2013", 
        "location": {
            "contact": {
                "email": "tstage@health.sdu.dk", 
                "last_name": "Tore B. Stage, MSc Pharm", 
                "phone": "+45 6550 3678"
            }, 
            "facility": {
                "address": {
                    "city": "Odense C", 
                    "country": "Denmark", 
                    "zip": "DK-5000"
                }, 
                "name": "Department of Clinical Pharmacology, Institute of Public Health, University of Southern Denmark"
            }, 
            "investigator": [
                {
                    "last_name": "Per Damkier, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Tore B. Stage, MSc Pharm", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "1", 
        "overall_contact": {
            "email": "tstage@health.sdu.dk", 
            "last_name": "Tore B. Stage, MSc Pharm", 
            "phone": "+45 6550 3678"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Southern Denmark", 
                "last_name": "Kim Br\u00f8sem, Professor, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "University of Southern Denmark", 
                "last_name": "Per Damkier, MD PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Southern Denmark", 
                "last_name": "Tore B. Stage, MSc Pharm", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Health and Medicines Authority", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "At time=0, the subjects will ingest 75g glucose. Plasma glucose will be measured at 0, 15, 30, 45, 60, 90 and 120 minutes after glucose ingestion.", 
            "measure": "Glucose area under curve (AUC) 0-2 hours", 
            "safety_issue": "Yes", 
            "time_frame": "Glucose concentration 0, 15, 30, 45, 60, 90 and 120 after glucose ingestion"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01921881"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Southern Denmark", 
            "investigator_full_name": "Tore B. Stage", 
            "investigator_title": "MSc Pharm", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "At time=0, the concentration of active components hypericin and hyperforin will be measured.", 
                "measure": "St John's wort pharmacokinetics", 
                "safety_issue": "No", 
                "time_frame": "At time=0"
            }, 
            {
                "description": "C-peptide and serum insulin will also be measured during the oral glucose tolerance test.", 
                "measure": "Other metabolic markers", 
                "safety_issue": "No", 
                "time_frame": "At time points, 0, 15, 30, 45, 60, 90, 120 minutes after glucose ingestion"
            }
        ], 
        "source": "University of Southern Denmark", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Southern Denmark", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}